PUBLISHER: TechNavio | PRODUCT CODE: 1915419
PUBLISHER: TechNavio | PRODUCT CODE: 1915419
Global Smallpox Treatment Market 2025-2029
The global smallpox treatment market is forecasted to grow by USD 89223.4 thousand during 2024-2029, accelerating at a CAGR of 2.3% during the forecast period. The report on the global smallpox treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing stockpiling of smallpox therapeutics, increasing drug approvals, increasing contract manufacturing practices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 2.2% |
| CAGR | 2.3% |
| Incremental Value | $89223.4 thousand |
Technavio's global smallpox treatment market is segmented as below:
By Product
- Drugs
- Vaccines
By Route Of Administration
- Intravenous
- Oral
- Topical
By End-User
- Hospitals
- Specialty clinics
- Homecare
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the increasing efforts by companies as one of the prime reasons driving the global smallpox treatment market growth during the next few years. Also, growing threat of bioterrorism and expedited approvals will lead to sizable demand in the market.
The report on the global smallpox treatment market covers the following areas:
- Global smallpox treatment market sizing
- Global smallpox treatment market forecast
- Global smallpox treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global smallpox treatment market vendors that include Bavarian Nordic AS, BioFactura Inc., Emergent BioSolutions Inc., EpiVax Inc., Inovio Pharmaceuticals Inc., KM Biologics Co. Ltd., Marker Therapeutics Inc., Oncovir Inc., Pfizer Inc., SIGA Technologies Inc., Tonix Pharmaceuticals Holding. Also, the global smallpox treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global Smallpox Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Smallpox Treatment Market 2019 - 2023 ($ thousand)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ thousand)
- 5.3 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ thousand)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ thousand)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ thousand)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Smallpox Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Drugs - Market size and forecast 2024-2029
- 8.4 Vaccines - Market size and forecast 2024-2029
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ thousand)
9 Market Segmentation by Route of Administration
- 9.1 Market segments
- 9.2 Comparison by Route of Administration
- 9.3 Intravenous - Market size and forecast 2024-2029
- 9.4 Oral - Market size and forecast 2024-2029
- 9.5 Topical - Market size and forecast 2024-2029
- 9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ thousand)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2024-2029
- 10.4 Specialty clinics - Market size and forecast 2024-2029
- 10.5 Homecare - Market size and forecast 2024-2029
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- 12.3.1 US - Market size and forecast 2024-2029
- 12.3.2 Canada - Market size and forecast 2024-2029
- 12.3.3 Mexico - Market size and forecast 2024-2029
- 12.4 Europe - Market size and forecast 2024-2029
- 12.4.1 Germany - Market size and forecast 2024-2029
- 12.4.2 UK - Market size and forecast 2024-2029
- 12.4.3 France - Market size and forecast 2024-2029
- 12.4.4 Italy - Market size and forecast 2024-2029
- 12.4.5 Spain - Market size and forecast 2024-2029
- 12.4.6 The Netherlands - Market size and forecast 2024-2029
- 12.5 Asia - Market size and forecast 2024-2029
- 12.5.1 China - Market size and forecast 2024-2029
- 12.5.2 India - Market size and forecast 2024-2029
- 12.5.3 Japan - Market size and forecast 2024-2029
- 12.5.4 South Korea - Market size and forecast 2024-2029
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- 12.5.6 Thailand - Market size and forecast 2024-2029
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 12.6.1 Brazil - Market size and forecast 2024-2029
- 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
- 12.6.3 UAE - Market size and forecast 2024-2029
- 12.6.4 Turkey - Market size and forecast 2024-2029
- 12.6.5 Argentina - Market size and forecast 2024-2029
- 12.6.6 Colombia - Market size and forecast 2024-2029
- 12.6.7 South Africa - Market size and forecast 2024-2029
- 12.6.8 Israel - Market size and forecast 2024-2029
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing stockpiling of smallpox therapeutics
- Increasing drug approvals
- Increasing contract manufacturing practices
- 13.2 Market challenges
- Complexities involved in vaccine storage and transportation
- Side-effects associated with smallpox vaccines
- Stringent regulatory environment
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Increasing efforts by companies
- Growing threat of bioterrorism
- Expedited approvals
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Bavarian Nordic AS
- Bavarian Nordic AS - Overview
- Bavarian Nordic AS - Product / Service
- Bavarian Nordic AS - Key offerings
- SWOT
- 15.5 BioFactura Inc.
- BioFactura Inc. - Overview
- BioFactura Inc. - Product / Service
- BioFactura Inc. - Key offerings
- SWOT
- 15.6 Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. - Overview
- Emergent BioSolutions Inc. - Product / Service
- Emergent BioSolutions Inc. - Key offerings
- SWOT
- 15.7 EpiVax Inc.
- EpiVax Inc. - Overview
- EpiVax Inc. - Product / Service
- EpiVax Inc. - Key offerings
- SWOT
- 15.8 Inovio Pharmaceuticals Inc.
- Inovio Pharmaceuticals Inc. - Overview
- Inovio Pharmaceuticals Inc. - Product / Service
- Inovio Pharmaceuticals Inc. - Key news
- Inovio Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.9 KM Biologics Co. Ltd.
- KM Biologics Co. Ltd. - Overview
- KM Biologics Co. Ltd. - Product / Service
- KM Biologics Co. Ltd. - Key offerings
- SWOT
- 15.10 Marker Therapeutics Inc.
- Marker Therapeutics Inc. - Overview
- Marker Therapeutics Inc. - Product / Service
- Marker Therapeutics Inc. - Key offerings
- SWOT
- 15.11 Oncovir Inc.
- Oncovir Inc. - Overview
- Oncovir Inc. - Product / Service
- Oncovir Inc. - Key offerings
- SWOT
- 15.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 15.13 SIGA Technologies Inc.
- SIGA Technologies Inc. - Overview
- SIGA Technologies Inc. - Product / Service
- SIGA Technologies Inc. - Key offerings
- SWOT
- 15.14 Tonix Pharmaceuticals Holding
- Tonix Pharmaceuticals Holding - Overview
- Tonix Pharmaceuticals Holding - Product / Service
- Tonix Pharmaceuticals Holding - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
